Washington HB2402 prohibits the manufacture, sale, and distribution of intravenous equipment containing certain phthalates.

Washington HB2402 addresses the use of phthalates in medical equipment for intravenous purposes. The bill prohibits the manufacture, sale, and distribution of intravenous tubing and containers containing intentionally added or unintentionally added Di(2-ethylhexyl) phthalate (DEHP) in quantities equal to or exceeding 0.1 percent. The prohibition on intravenous tubing takes effect January 1, 2028, and for containers, January 1, 2035. The bill also bans replacing DEHP with other ortho-phthalates in new or revised products.

Washington HB2402 prohibits the manufacture, sale, and distribution of intravenous equipment containing certain phthalates.

Washington HB2402 addresses the use of phthalates in medical equipment for intravenous purposes. The bill prohibits the manufacture, sale, and distribution of intravenous tubing and containers containing intentionally added or unintentionally added Di(2-ethylhexyl) phthalate (DEHP) in quantities equal to or exceeding 0.1 percent. The prohibition on intravenous tubing takes effect January 1, 2028, and for containers, January 1, 2035. The bill also bans replacing DEHP with other ortho-phthalates in new or revised products.